Cargando…

Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

BACKGROUND: Among US adults, utilization of pharmacotherapy for attention-deficit hyperactivity disorder (ADHD) has increased more than ninefold since 1995–1996. Potential contraindications to ADHD pharmacotherapy include serious cardiovascular disease (CVD) and, for stimulants, addictions and bipol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fairman, Kathleen A., Davis, Lindsay E., Peckham, Alyssa M., Sclar, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825392/ https://www.ncbi.nlm.nih.gov/pubmed/29305714 http://dx.doi.org/10.1007/s40801-017-0129-2

Ejemplares similares

Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance
por: Peckham, Alyssa M, et al.
Publicado: (2018)

Use of power-law analysis to predict abuse or diversion of prescribed medications: proof-of-concept mathematical exploration
por: Fairman, Kathleen A., et al.
Publicado: (2018)

A critical appraisal of atomoxetine in the management of ADHD
por: Childress, Ann C
Publicado: (2015)

Atomoxetine: a novel treatment for child and adult ADHD
por: Ledbetter, Marcialee
Publicado: (2006)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009)

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice
por: Fairman, Kathleen A, et al.
Publicado: (2017)

Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits
por: Molina, Kyle C, et al.
Publicado: (2018)

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
por: Treuer, Tamás, et al.
Publicado: (2016)

Off-label use of atomoxetine in adults: is it safe?
por: Dadashova, Rana, et al.
Publicado: (2012)

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
por: Dittmann, Ralf W, et al.
Publicado: (2009)

Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Moon, Su Jin, et al.
Publicado: (2014)

Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder
por: Houghton, Richard, et al.
Publicado: (2019)

Targeting Nicotine Addiction in a Substance Abuse Program
por: Sharp, James R., et al.
Publicado: (2003)

Overlap between substance and behavioural addictions: substance abuse in patients with pathological gambling
por: Cunha E Costa, N., et al.
Publicado: (2022)

Atomoxetine as an Alternative Therapy for Adolescent Adhd With Comorbid Cerebral Palsy: A Case Report
por: Calilung, Dominique, et al.
Publicado: (2023)

Childhood risk factors for substance abuse in a clinical sample of adults with attention-deficit / hyperactivity disorder (ADHD) symptoms in an addiction outpatient clinic
por: Laizāne, M., et al.
Publicado: (2021)

Acute atomoxetine treatment of younger and older children with ADHD: A meta-analysis of tolerability and efficacy
por: Kratochvil, Christopher J, et al.
Publicado: (2008)

Acute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: A fNIRS study
por: Nagashima, Masako, et al.
Publicado: (2014)

Substance abuse and neurotransmission
por: Davis, Sarah, et al.
Publicado: (2022)

Shared and Drug-Specific Effects of Atomoxetine and Methylphenidate on Inhibitory Brain Dysfunction in Medication-Naive ADHD Boys
por: Cubillo, Ana, et al.
Publicado: (2014)

The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review
por: Fu, Di, et al.
Publicado: (2022)

Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD
por: Kowalczyk, Olivia S., et al.
Publicado: (2023)

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

Physiological, Psychosocial and Substance Abuse Effects of Pornography Addiction: A Narrative Review
por: Mehmood Qadri, Haseeb, et al.
Publicado: (2023)

Tanning as a substance abuse
por: Robinson, Kathleen C, et al.
Publicado: (2014)

Influence of Atomoxetine on Relationship Between ADHD Symptoms and Prefrontal Cortex Activity During Task Execution in Adult Patients
por: Sugimoto, Atsunori, et al.
Publicado: (2021)

Factors Associated With Initiation With Atomoxetine Versus Stimulants in the Treatment of Adults With ADHD: Retrospective Analysis of Administrative Claims Data
por: Van Brunt, David L., et al.
Publicado: (2006)

Which factors influence psychiatric diagnosing in substance abuse treatment?
por: Wynn, Rolf, et al.
Publicado: (2013)

Adoption of telemedicine services by substance abuse treatment facilities in the U.S.
por: Uscher-Pines, Lori, et al.
Publicado: (2020)

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder
por: Upadhyaya, Himanshu P., et al.
Publicado: (2013)

Evolutionary and neuropsychological perspectives on addictive behaviors and addictive substances: relevance to the “food addiction” construct
por: Davis, Caroline
Publicado: (2014)

The Effectiveness of Emotion Regulation Training and Cognitive Therapy on the Emotional and Addictional Problems of Substance Abusers
por: Azizi, Alireza, et al.
Publicado: (2010)

Mindfulness based stress reduction among substance abuse patients at de-addiction center
por: D, Alfred Solomon, et al.
Publicado: (2022)

The influence of reported ADHD and substance abuse on suicidal ideation in a non-clinical sample of young men
por: Huemer, Julia, et al.
Publicado: (2016)

Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies
por: Wehmeier, Peter M, et al.
Publicado: (2009)

High-risk opioid prescribing trends in the outpatient setting prior to issuance of federal guidance
por: Peckham, Alyssa M., et al.
Publicado: (2019)

Substance-specific variability of ADHD symptoms in riga psychiatry and addiction medicine centre treatment-seeking substance use disorder outpatient population
por: Ennītis, M., et al.
Publicado: (2021)

3099 Risk of substance abuse onset in adults diagnosed with epilepsy or migraine
por: Jones, Stephanie, et al.
Publicado: (2019)

Substance-Related Problems in Adolescents with ADHD-Diagnoses: The Importance of Self-Reported Conduct Problems
por: Heradstveit, Ove, et al.
Publicado: (2022)

ADD or ADHD or What Exactly?--GIGO Part II and Other Lessons in Research with Administrative Claims
por: Curtiss, Frederic R., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_rhqnimbenavjnnm6hqkcumq9o6